Literature DB >> 9467142

Sexual dysfunction in primary medical care: prevalence, characteristics and detection by the general practitioner.

S Read1, M King, J Watson.   

Abstract

BACKGROUND: Despite the recent focus on sexual behaviour and AIDs, there are almost no data on the prevalence of sexual dysfunction within primary care settings.
METHOD: One hundred and seventy patients attending a general practice participated in a questionnaire survey of the prevalence and characteristics of sexual problems. The detection rate of the general practitioners (GPs) and indicators in the patient notes were also investigated.
RESULTS: Thirty five per cent of the men (n = 22) reported some form of specific sexual dysfunction: premature ejaculation was identified in 31 per cent of the men; 17 per cent experienced erectile dysfunction, which was associated with current medication, a high mean annual attendance and increasing age. The prevalence of sexual dysfunction in the women was 42 per cent (n = 41); vaginismus was reported by 30 per cent of the sample; 23 per cent of the women suffered from anorgasmia. General sexual dissatisfaction was more common than specific dysfunction; 68 per cent (n = 66) of the women and 75 per cent (n = 54) of the men reported at least one problem with dissatisfaction, avoidance, infrequency or non-communication. The large majority of the sample (70 per cent) considered sexual matters to be an appropriate topic for the GP to discuss. Despite this, sexual problems were recorded in only 2 per cent of the GP notes.
CONCLUSIONS: This study confirms the high prevalence of sexual disorders in the population. Many of these problems are concealed from GPs. Predictors in patients' notes could help GPs to detect those patients with more serious problems.

Entities:  

Mesh:

Year:  1997        PMID: 9467142     DOI: 10.1093/oxfordjournals.pubmed.a024665

Source DB:  PubMed          Journal:  J Public Health Med        ISSN: 0957-4832


  30 in total

1.  Viagra and broken hearts.

Authors:  S Holzapfel
Journal:  Can Fam Physician       Date:  2000-02       Impact factor: 3.275

2.  The effect of posterior colporrhaphy performed concurrently with midurethral sling surgery on the sexual function of women with stress urinary incontinence.

Authors:  Tae Yoong Jeong; Seung Ae Yang; Ju Tae Seo
Journal:  Int Neurourol J       Date:  2010-10-31       Impact factor: 2.835

3.  Managing early ejaculation: what does the future hold?

Authors:  Michael P O'leary
Journal:  Rev Urol       Date:  2004

Review 4.  Prevalence of sexual dysfunctions: results from a decade of research.

Authors:  J S Simons; M P Carey
Journal:  Arch Sex Behav       Date:  2001-04

5.  Sexual function in women after surgery for pelvic organ prolapse.

Authors:  Mahyar Azar; Sima Noohi; Shokoufeh Radfar; Mohammad Hadi Radfar
Journal:  Int Urogynecol J Pelvic Floor Dysfunct       Date:  2007-06-15

6.  Is Physical Alteration a Sufficient Reason to Prohibit Ritual Infant Circumcision?

Authors:  Allan J Jacobs
Journal:  J Relig Health       Date:  2021-01-03

Review 7.  Impact of Antidepressant Drugs on Sexual Function and Satisfaction.

Authors:  David S Baldwin; Chris Manson; Magda Nowak
Journal:  CNS Drugs       Date:  2015-11       Impact factor: 5.749

8.  Increasing orgasm and decreasing dyspareunia by a manual physical therapy technique.

Authors:  Lawrence J Wurn; Belinda F Wurn; C Richard King; Amanda S Roscow; Eugenia S Scharf; Jonathan J Shuster
Journal:  MedGenMed       Date:  2004-12-14

9.  The effect of overactive bladder treatment with anticholinergics on female sexual function in women: a prospective observational study.

Authors:  Suleyman Sami Cakir; Recep Burak Degirmentepe; Hasan Anil Atalay; Halil Lutfi Canat; Sait Ozbir; Mehmet Gokhan Culha; Emre Can Polat; Alper Otunctemur
Journal:  Int Urol Nephrol       Date:  2018-11-17       Impact factor: 2.370

Review 10.  Phosphodiesterase 5 inhibitors in rapid ejaculation: potential use and possible mechanisms of action.

Authors:  Ibrahim A Abdel-Hamid
Journal:  Drugs       Date:  2004       Impact factor: 9.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.